114 related articles for article (PubMed ID: 12072919)
1. Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study).
Schäfer G; Hoffmann C; Arasteh K; Schürmann D; Stephan C; Jensen B; Stoll M; Bogner JR; Faetkenheuer G; Rockstroh J; Klinker H; Härter G; Stöhr A; Degen O; Freiwald E; Hüfner A; Jordan S; Schulze Zur Wiesch J; Addo M; Lohse AW; van Lunzen J; Schmiedel S;
AIDS Res Ther; 2019 Nov; 16(1):34. PubMed ID: 31729999
[TBL] [Abstract][Full Text] [Related]
2. Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE.
Atkinson A; Zwahlen M; Barger D; d'Arminio Monforte A; De Wit S; Ghosn J; Girardi E; Svedhem V; Morlat P; Mussini C; Noguera-Julian A; Stephan C; Touloumi G; Kirk O; Mocroft A; Reiss P; Miro JM; Carpenter JR; Furrer H;
Clin Infect Dis; 2021 Jul; 73(2):195-202. PubMed ID: 32448894
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Short-Term, Intensive Antifolate Treatment (with Pyrimethamine and Sulfadoxine) and Antibiotics Followed by Long-Term, Secondary Antifolate Prophylaxis on the Rate of Toxoplasmic Retinochoroiditis Recurrence.
Borkowski PK; Brydak-Godowska J; Basiak W; Świtaj K; Żarnowska-Prymek H; Olszyńska-Krowicka M; Kajfasz P; Rabczenko D
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004892. PubMed ID: 27542116
[TBL] [Abstract][Full Text] [Related]
4. Toxoplasmic encephalitis with high
Nakamura S; Hara K; Kobayashi T; Sumitani R; Oura M; Maeda Y; Sogabe K; Yagi H; Takahashi M; Fujii S; Harada T; Bando Y; Abe M; Miki H
Parasitol Int; 2024 Aug; 101():102895. PubMed ID: 38614255
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis prophylaxis for all, some, or no HIV-infected infants less than one year of age: A decision analysis approach.
Allen UD; Read SE
Can J Infect Dis; 1993 Nov; 4(6):333-40. PubMed ID: 22346469
[TBL] [Abstract][Full Text] [Related]
6. A Blast From the Past: Toxoplasmic Encephalitis As the Initial Presentation of HIV/AIDS.
Ortiz OR; Norris T
Cureus; 2024 Apr; 16(4):e58693. PubMed ID: 38651086
[TBL] [Abstract][Full Text] [Related]
7. Brief Report: Financial Burden of Toxoplasmosis Encephalitis Treatment at a Safety Net Hospital.
Bogard SN; Lee JT; Patel M; Kempker RR
J Acquir Immune Defic Syndr; 2022 Nov; 91(3):276-279. PubMed ID: 36252242
[TBL] [Abstract][Full Text] [Related]
8. Persistence of Human Immunodeficiency Virus-Associated Cerebral Toxoplasmosis Lesions in Successfully Treated Patients Receiving Combination Antiretroviral Therapy.
Coleman B; Smith BR; Kapoor R; Proschan MA; Sereti I; Hammoud DA; Kovacs JA
Open Forum Infect Dis; 2023 May; 10(5):ofad208. PubMed ID: 37213420
[TBL] [Abstract][Full Text] [Related]
9. Clonal expansion of CD4
Volkers SM; Meisel C; Terhorst-Molawi D; Burbach GJ; Schürmann D; Suttorp N; Sander LE
Allergy Asthma Clin Immunol; 2021 Feb; 17(1):17. PubMed ID: 33568212
[TBL] [Abstract][Full Text] [Related]
10. The common HAQ STING variant impairs cGAS-dependent antibacterial responses and is associated with susceptibility to Legionnaires' disease in humans.
Ruiz-Moreno JS; Hamann L; Shah JA; Verbon A; Mockenhaupt FP; Puzianowska-Kuznicka M; Naujoks J; Sander LE; Witzenrath M; Cambier JC; Suttorp N; Schumann RR; Jin L; Hawn TR; Opitz B;
PLoS Pathog; 2018 Jan; 14(1):e1006829. PubMed ID: 29298342
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of weekly docetaxel-cisplatin as first-line treatment for advanced non-small cell lung cancer.
Binder D; Hackenthal M; Graseck L; Schweisfurth H; Schäper C; Krüll M; Temmesfeld-Wollbrück B; Suttorp N; Beinert T; Hellriegel KP
J Thorac Oncol; 2009 Sep; 4(9):1144-7. PubMed ID: 19609222
[TBL] [Abstract][Full Text] [Related]
12. Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections.
Chico RM; Chaponda EB; Ariti C; Chandramohan D
Clin Infect Dis; 2017 Apr; 64(8):1043-1051. PubMed ID: 28329383
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of and diagnostic strategies for toxoplasmosis.
Robert-Gangneux F; Dardé ML
Clin Microbiol Rev; 2012 Apr; 25(2):264-96. PubMed ID: 22491772
[TBL] [Abstract][Full Text] [Related]
14. Correlation of parasite load determined by quantitative PCR to clinical outcome in a heart transplant patient with disseminated toxoplasmosis.
Patrat-Delon S; Gangneux JP; Lavoué S; Lelong B; Guiguen C; le Tulzo Y; Robert-Gangneux F
J Clin Microbiol; 2010 Jul; 48(7):2541-5. PubMed ID: 20463167
[TBL] [Abstract][Full Text] [Related]
15. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
Peters PJ; Thigpen MC; Parise ME; Newman RD
Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents.
Kim YA; Sharon A; Chu CK; Rais RH; Al Safarjalani ON; Naguib FN; el Kouni MH
Biochem Pharmacol; 2007 May; 73(10):1558-72. PubMed ID: 17306769
[TBL] [Abstract][Full Text] [Related]
17. Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.
Rodriguez M; Fishman JA
Clin Microbiol Rev; 2004 Oct; 17(4):770-82, table of contents. PubMed ID: 15489347
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
[TBL] [Abstract][Full Text] [Related]
19. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
Schürmann D; Bergmann F; Albrecht H; Padberg J; Grünewald T; Behnsch M; Grobusch M; Vallée M; Wünsche T; Ruf B; Suttorp N
J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
